glp-1 inflammation reduction The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury Impact of GLP-1 on different

GLP-1 receptor agonists including Ozempic, Wegovy (semaglutide), Mounjaro, and Zepbound (tirzepatide) were developed to treat type 2 diabetes and, more recently, chronic weight management

Beaton, M

(5) Immunometabolic Reprogramming: Polarization of ATMs toward M2 phenotypes with concurrent suppression of NF-B/STAT3 inflammatory cascades

For example, a smaller ACL with tightly packed collagen fibers may have different viscoelastic properties compared to a larger ligament with a more loosely organized collagen matrix

Gender differences in macroprolactinomas: study of clinical features, outcome of patients and ki-67 expression in tumor tissue